
Opdivo-Chemo Combo Before Surgery Improves Long-Term Lung Cancer Survival, Pivotal Trial Finds
Adding Opdivo (nivolumab) to chemotherapy before surgery significantly improves long-term overall survival compared to chemotherapy alone in patients with operable non-small cell lung cancer (NSCLC), according to a five-year analysis of a phase 3 trial. …